Crystagen
Price range: £30.00 through £50.00
CAS No: On request
Strengths Available: 20mg
Format: Sealed containment / vial presentations available
Volume: 3mL
What This Product Is About
Crystagen belongs to a class of short peptide bioregulators frequently referenced in longevity and cellular-regulation research. It has attracted scientific attention as a research tool for exploring how short peptides may influence gene expression and tissue maintenance.
Description
What is Crystagen?
Crystagen is a research-grade peptide bioregulator studied in the context of cellular regulation, ageing biology, and tissue-specific signalling.
Investigators have explored how Crystagen may interact with regulatory pathways associated with cellular maintenance and renewal in laboratory models.
Why Researchers Became Interested in Crystagen
Researchers became interested in Crystagen because of its relevance to cellular-regulation and longevity research.
It provides a defined research tool for examining tissue-specific regulatory pathways in experimental models.
Key Research Focus Areas
- Cellular-regulation and gene-expression models
- Ageing and longevity research
- Tissue-specific maintenance and renewal studies
- Antioxidant and cytoprotective pathway research
- Neuroendocrine signalling investigations
- Bioregulator mechanism studies
What the Research Has Shown
In preclinical research, Crystagen has been studied for its association with cellular-regulation and tissue-maintenance pathways. Mechanistic studies have explored how short peptide bioregulators may influence gene expression in target tissues.
Scientific Background and Research Context
Crystagen is a short synthetic peptide, commonly identified by the amino-acid sequence Glu-Asp-Pro (EDP). It has been investigated within the broader field of thymic peptide bioregulation, with particular interest in cellular communication, immune-system regulation, gene expression and age-related changes in thymus function. Research remains largely experimental, and Crystagen is not established as an approved treatment for any medical condition.
Exploring the Science Behind Crystagen
Scientific investigation of Crystagen focuses on how short peptides may interact with cellular regulatory mechanisms. Laboratory research suggests that some short peptides may enter cell nuclei and interact with chromatin, histone proteins or specific regions of DNA involved in transcription. Researchers are examining whether the EDP sequence may influence protein synthesis and the activity of genes associated with thymic and immune-cell function. These proposed mechanisms require further independent confirmation.
Research Context in Endocrine and Metabolic Science
Although Crystagen is primarily associated with thymic and immunological research, the thymus does not operate independently from the endocrine and metabolic systems. Immune signalling, hormonal regulation, stress responses, energy balance and ageing-related cellular changes are closely interconnected. For this reason, researchers may study thymic peptides within wider investigations of systemic homeostasis, stress adaptation and age-associated changes in endocrine, immune and metabolic regulation. Evidence specific to Crystagen in these areas remains limited and should be interpreted cautiously.
Ongoing Scientific Interest
Crystagen continues to attract scientific interest because short regulatory peptides may provide useful models for studying gene expression, cellular ageing, thymic function and immune-system communication. Experimental studies have explored the effects of EDP-related peptides on normal lymphocytes, cellular proliferation and thymic tissue under models of accelerated ageing or physiological stress. However, additional well-controlled research is needed to establish reproducibility, clarify biological mechanisms and determine the relevance of these observations to human physiology.
Ingredient Profile
Single research compound: Crystagen
CAS: On request
Purity >99%
Supplied as lyophilised powder (no excipients, fillers or additives).
Active Ingredients
Crystagen— 20mg
Ingredient Breakdown
Cagrisema: 20mg of active peptide per vial (lyophilised).
Why is Crystagen described as a peptide bioregulator?
Because it belongs to a class of short peptides studied for their influence on cellular regulation and gene expression.
Is Crystagen approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.
Why does purity matter so much for this product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.
What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.
Is international supply available?
Yes. International fulfilment and temperature-controlled shipping can be supported where appropriate.
Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.
Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.
Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.
For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.
Partner with FreshstartPharma– Where Accuracy Meets Innovation
Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.
Related Products
GHK-Cu
Oxytocin
Ipamorelin
